Special Correspondent : ICC Animal Nutrition, in partnership with ACE Pharmaceuticals, successfully hosted a technical seminar titled “Immune Connection: Driving Performance Through Integrated Health & Immunity” today ( 13 June ) at Dhaka Regency Hotel & Resort, bringing together leading nutritionists, veterinarians, consultants, feed manufacturers, and aquaculture professionals from across Bangladesh.
The event opened with a presentation by Dr. Rajib Dutta, Technical Business Manager (South Asia), who highlighted ICC Animal Nutrition’s global expertise in yeast-based nutritional technologies and its commitment to improving animal health, performance, and sustainability.
A key session by Dr. Kuo Wei Ssu, Sales Director – Asia, focused on “Redefining Yeast: The ICC Uniqueness.” He explained how ICC’s proprietary sugarcane ethanol yeast technology differs from conventional baker’s and brewer’s yeast, delivering superior consistency, functionality, and performance through its unique production process and bioactive components.
The keynote presentation was delivered by Dr. Melina Bonato, Global Technical & R&D Manager, on the vital connection between gut health, immunity, and animal performance. She highlighted the benefits of hydrolyzed yeast solutions such as Hilyses® in aquaculture nutrition and presented results from a Nile tilapia trial conducted in Bangladesh, demonstrating significant improvements in fish health and performance under local farming conditions. Dr. Bonato also shared findings of this trial published in an international peer-reviewed scientific journal, reinforcing the scientific foundation of ICC’s technologies.
The seminar concluded with an interactive discussion session and closing remarks from Dr. Mostafa Alam, CEO of ACE Pharmaceuticals, who emphasized the importance of innovation, scientific collaboration, and preventive nutrition in advancing Bangladesh’s livestock, poultry, and aquaculture industries. He also expressed his gratefulness to all industry stakeholder for supporting both ICC & ACE Pharmaceuticals for the last 10 years specially in making ImmunoWall the market leader since 2018.
Dr. Alam also announced that ACE Pharmaceuticals has officially begun distributing ICC’s FIX LINE® solutions in Bangladesh. The yeast-based mycotoxin binder range provides broad-spectrum protection against major mycotoxins, helping producers safeguard animal health, optimize performance and improve profitability.
This collaboration further strengthens the commitment of ICC Animal Nutrition and ACE Pharmaceuticals in delivering science-driven nutritional solutions that support sustainable animal production in Bangladesh.
About ICC Animal Nutrition
ICC Animal Nutrition is a global leader in yeast-based nutritional technologies, dedicated in improving animal health, performance, and sustainability through innovative and scientifically validated solutions. With more than 33 of expertise in yeast biotechnology, ICC develops and manufactures a comprehensive portfolio of specialty ingredients, including yeast cell walls, autolyzed yeast, hydrolyzed yeast, yeast extracts, mycotoxin risk management solutions, and flavoring technologies for animal nutrition.
ICC’s products are used across poultry, aquaculture, ruminant, swine, and pet food industries in more than 70 countries worldwide. Backed by extensive research, field validation, and collaborations with leading universities and research institutions, ICC continuously invests in innovation to help producers improve gut health, immunity, feed efficiency, productivity, and profitability while adding value to animal nutrition and supporting sustainable animal production as well.
